Target Price | €51.00 |
Price | €48.15 |
Potential | 5.92% |
Number of Estimates | 19 |
19 Analysts have issued a price target Fresenius 2026 . The average Fresenius target price is €51.00. This is 5.92% higher than the current stock price. The highest price target is €59.85 24.30% , the lowest is €42.42 11.90% . | |
A rating was issued by 23 analysts: 20 Analysts recommend Fresenius to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Fresenius stock has an average upside potential 2026 of 5.92% . Most analysts recommend the Fresenius stock at Purchase. |
20 Analysts have issued a sales forecast Fresenius 2025 . The average Fresenius sales estimate is €22.9b . This is 2.87% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €24.5b 10.17% , the lowest is €21.9b 1.42% .
This results in the following potential growth metrics:
2024 | €21.8b | 3.64% |
---|---|---|
2025 | €22.9b | 4.74% |
2026 | €24.0b | 4.92% |
2027 | €25.1b | 4.81% |
2028 | €26.5b | 5.31% |
2029 | €27.7b | 4.48% |
2030 | €27.7b | 0.06% |
2031 | €28.8b | 4.23% |
18 Analysts have issued an Fresenius EBITDA forecast 2025. The average Fresenius EBITDA estimate is €3.8b . This is 69.32% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €4.1b 82.28% , the lowest is €3.5b 56.26% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €1.8b | 43.32% |
---|---|---|
2025 | €3.8b | 109.16% |
2026 | €4.1b | 8.42% |
2027 | €4.4b | 5.78% |
2028 | €4.5b | 3.41% |
2029 | €4.7b | 4.75% |
2024 | 8.35% | 38.29% |
---|---|---|
2025 | 16.67% | 99.65% |
2026 | 17.23% | 3.36% |
2027 | 17.39% | 0.93% |
2028 | 17.08% | 1.78% |
2029 | 17.12% | 0.23% |
19 Fresenius Analysts have issued a net profit forecast 2025. The average Fresenius net profit estimate is €1.9b . This is 71.00% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.1b 84.52% , the lowest is €1.8b 61.42% .
This results in the following potential growth metrics and future Net Margins:
2024 | €471m | 179.29% |
---|---|---|
2025 | €1.9b | 308.44% |
2026 | €2.1b | 8.61% |
2027 | €2.3b | 8.31% |
2028 | €2.5b | 11.51% |
2029 | €2.7b | 7.44% |
2030 | €2.7b | 1.04% |
2024 | 2.16% | 176.51% |
---|---|---|
2025 | 8.41% | 289.84% |
2026 | 8.71% | 3.57% |
2027 | 9.00% | 3.33% |
2028 | 9.53% | 5.89% |
2029 | 9.80% | 2.83% |
2030 | 9.91% | 1.12% |
19 Analysts have issued a Fresenius forecast for earnings per share. The average Fresenius EPS is €3.42 . This is 73.60% higher than earnings per share in the financial year 2024. The highest EPS forecast is €3.69 87.31% , the lowest is €3.22 63.45% .
This results in the following potential growth metrics and future valuations:
2024 | €0.83 | 179.05% |
---|---|---|
2025 | €3.42 | 312.05% |
2026 | €3.71 | 8.48% |
2027 | €4.02 | 8.36% |
2028 | €4.48 | 11.44% |
2029 | €4.81 | 7.37% |
2030 | €4.86 | 1.04% |
Current | 24.44 | 149.00% |
---|---|---|
2025 | 14.10 | 42.31% |
2026 | 12.98 | 7.94% |
2027 | 11.98 | 7.70% |
2028 | 10.75 | 10.27% |
2029 | 10.00 | 6.98% |
2030 | 9.90 | 1.00% |
Based on analysts' sales estimates for 2025, the Fresenius stock is valued at an EV/Sales of 1.60 and an P/S ratio of 1.16 .
This results in the following potential growth metrics and future valuations:
Current | 1.64 | 21.48% |
---|---|---|
2025 | 1.60 | 2.59% |
2026 | 1.52 | 4.69% |
2027 | 1.45 | 4.59% |
2028 | 1.38 | 5.05% |
2029 | 1.32 | 4.28% |
2030 | 1.32 | 0.06% |
2031 | 1.27 | 4.06% |
Current | 1.19 | 36.49% |
---|---|---|
2025 | 1.16 | 2.79% |
2026 | 1.10 | 4.69% |
2027 | 1.05 | 4.59% |
2028 | 1.00 | 5.04% |
2029 | 0.96 | 4.29% |
2030 | 0.96 | 0.06% |
2031 | 0.92 | 4.06% |
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Buy
➜
Buy
|
Unchanged | Sep 16 2025 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Sep 11 2025 |
DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Sep 08 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Hold
➜
Buy
|
Upgrade | Aug 29 2025 |
METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | Aug 29 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Aug 26 2025 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Jul 01 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Sep 16 2025 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Sep 11 2025 |
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Sep 08 2025 |
Upgrade
LANDESBANK BADEN-WUERTTEMBERG:
Hold
➜
Buy
|
Aug 29 2025 |
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
Aug 29 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Aug 26 2025 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Jul 01 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.